Structure-activity relationships and structural conformation of a novel urotensin II-related peptide

被引:87
作者
Chatenet, D
Dubessy, C
Leprince, J
Boularan, C
Carlier, L
Ségalas-Milazzo, I
Guilhaudis, L
Oulyadi, H
Davoust, D
Scalbert, E
Pfeiffer, B
Renard, P
Tonon, MC
Lihrmann, I
Pacaud, P
Vaudry, H [1 ]
机构
[1] Univ Rouen, UA CNRS, European Inst Peptide Res IFRMP 23, INSERM U413,Lab Cellular & Mol Neuroendocrinol, F-76821 Mont St Aignan, France
[2] Univ Rouen, CNRS UMR 6014, European Inst Peptide Res IFRMP 23, Lab Nucl Magnet Resonance, F-76821 Mont St Aignan, France
[3] IdRs, F-92150 Suresnes, France
[4] Univ Nantes, INSERM, U533, Lab Cellular & Mol Physiopathol & Pharmacol, F-44322 Nantes, France
关键词
urotensin II-related peptide; urotensin II receptor; solid-phase peptide synthesis; ala-scan; D-scan; NMR; conformational analysis; structure-activity relationships; ligand binding; rat aortic ring contraction;
D O I
10.1016/j.peptides.2004.04.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Urotensin II (UII) has been described as the most potent vasoconstrictor peptide and recognized as the endogenous ligand of the orphan G protein-coupled receptor GPR14. Recently, a UII-related peptide (URP) has been isolated from the rat brain and its sequence has been established as H-Ala-Cys-Phe-Trp-Lys-Tyr-Cys-Val-OH. In order to study the structure-function relationships of URP, we have synthesized a series of URP analogs and measured their binding affinity on hGPR14-transfected cells and their contractile activity in a rat aortic ring bioassay. Alanine substitution of each residue of URP significantly reduced the binding affinity and the contractile activity of the peptides, except for the Ala(8)-substituted analog that retained biological activity. Most importantly, D-scan of URP revealed that [D-Trp(4)]URP abrogated and [D-Tyr(6)]URP partially suppressed the UII-evoked contractile response. [Orn(5)]URP, which had very low agonistic efficacy, was the most potent antagonist in this series. The solution structure of URP has been determined by H-1 NMR spectroscopy and molecular dynamics. URP exhibited a single conformation characterized by an inverse gamma-turn comprising residues Trp-Lys-Tyr which plays a crucial role in the biological activity of URP. These pharmacological and structural data should prove useful for the rational design of non-peptide ligands as potential GPR14 agonists and antagonists. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1819 / 1830
页数:12
相关论文
共 72 条
[1]  
ALBERICIO F, 1991, INT J PEPT PROT RES, V37, P402
[2]   Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 [J].
Ames, RS ;
Sarau, HM ;
Chambers, JK ;
Willette, RN ;
Alyar, NV ;
Romanic, AM ;
Louden, CS ;
Foley, JJ ;
Sauermelch, CF ;
Coatney, RW ;
Ao, ZH ;
Disa, J ;
Holmes, SD ;
Stadel, JM ;
Martin, JD ;
Liu, WS ;
Glover, GI ;
Wilson, S ;
McNulty, DE ;
Ellis, CE ;
Elshourbagy, NA ;
Shabon, U ;
Trill, JJ ;
Hay, DWP ;
Ohlstein, EH ;
Bergsma, DJ ;
Douglas, SA .
NATURE, 1999, 401 (6750) :282-286
[3]  
Basille M, 2000, J COMP NEUROL, V425, P495
[4]  
BECKSICKINGER AG, 1990, INT J PEPT PROT RES, V36, P522
[5]   Pharmacological characterization of SB-710411 (Cpa-c[D-Cys-Pal-D-Trp-Lys-Val-Cys]-Cpa-amide), a novel peptidic urotensin-II receptor antagonist [J].
Behm, DJ ;
Herold, CL ;
Ohlstein, EH ;
Knight, SD ;
Dhanak, D ;
Douglas, SA .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 137 (04) :449-458
[6]   Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice [J].
Behm, DJ ;
Harrison, SM ;
Ao, ZH ;
Maniscalco, K ;
Pickering, SJ ;
Grau, EV ;
Woods, TN ;
Coatney, RW ;
Doe, CPA ;
Willette, RN ;
Johns, DG ;
Douglas, SA .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 139 (02) :464-472
[7]   NMR AND DYNAMICAL SIMULATED ANNEALING STUDIES ON THE SOLUTION CONFORMATION OF UROTENSIN-II [J].
BHASKARAN, R ;
ARUNKUMAR, AI ;
YU, C .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1994, 1199 (02) :115-122
[8]   A new ligand for the urotensin II receptor [J].
Camarda, V ;
Guerrini, R ;
Kostenis, E ;
Rizzi, A ;
Calò, G ;
Hattenberger, A ;
Zucchini, M ;
Salvadori, S ;
Regoli, D .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 137 (03) :311-314
[9]   Effects of human urotensin II in isolated vessels of various species;: comparison with other vasoactive agents [J].
Camarda, V ;
Rizzi, A ;
Calò, G ;
Gendron, G ;
Perron, SI ;
Kostenis, E ;
Zamboni, P ;
Mascoli, F ;
Regoli, D .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 (02) :141-149
[10]  
Cann J R, 1983, Adv Exp Med Biol, V156, P495